Digostics Limited
10.4.2024 10:22:10 CEST | ACCESS Newswire | Press release
Digostics and AgaMatrix Team Up to Improve Gestational Diabetes Screening for UK Women via the Introduction of Oral Glucose Tolerance Home Testing
OXFORD, UK / ACCESSWIRE / April 10, 2024 / Digital clinical diagnostics and diabetes home testing provider Digostics Limited announced today a new commercial partnership with leading diabetes technology company, AgaMatrix Europe Limited, designed to accelerate the introduction of Digostics' home oral glucose tolerance testing (OGTT) service, GTT@home, for gestational diabetes (GDM) screening within the UK National Health Service (NHS).
GTT@home represents the world's first and only commercially available OGTT approved for home use. The partnership enables AgaMatrix to distribute GTT@home to the NHS on an exclusive basis. This news also follows the recent announcement of the significantly improved uptake in OGTT attributed to home testing experienced by University Hospital Southampton (UHS), and GTT@home's full inclusion in the Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services framework operated by NHS Supply Chain.
Image: The GTT@home Test Kit includes the novel test device, a preformulated glucose drink, finger prickers, a test user guide and a prepaid envelope. It is packaged to fit safely in the recipient's home letterbox.
"The significant reductions in maternity services workload and improvements in test accessibility achieved by taking GDM screening directly to the expectant mother has generated huge domestic and international demand for GTT@home," said James Jackson, CEO and Founder of Digostics. "AgaMatrix is the perfect partner to help Digostics expedite GTT@home's UK introduction based on its existing relationships and customer base within NHS maternity services and their unparalleled domain expertise in GDM monitoring."
While the OGTT is the gold standard in GDM screening, delayed and missed tests are common based on the inconvenience for women and complexity for healthcare providers of the traditional clinic-based method of OGTT delivery. OGTT uptake is also unfortunately lowest with those patient groups most at-risk of developing the condition.
GTT@home removes the barriers associated with effective diabetes screening by enabling women to test for glucose intolerance outside of the clinic for the very first time. Home testing offers the same level of accuracy as clinic tests but without any of the staffing requirements, risks of sample degradation and laboratory delays that often impact clinic testing capacity, contribute to screening backlogs and cause false negative tests.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Image: With GTT@home, the user can send their test data directly to their antenatal care team with a simple scan of a snap-off fob attached to the test device using the NFC functionality within their smartphone.
"Our daily interaction with customers means we see up close just how difficult it is for maternity service departments to deliver timely GDM testing. We also know just how excited they are at the prospect of being able to improve their testing throughput by introducing home screening," said Alec Winton, Business Manager Europe, AgaMatrix Europe. "We could not be more excited to partner with Digostics and to add GTT@home to our growing portfolio of ways in which we can assist the NHS manage diabetes in pregnancy."
With GTT@home simplifying GDM testing and AgaMatrix' technologies assisting with the management of those diagnosed positive, the partnership also provides additional scope for a closer technical integration between their respective solutions.
"The complementary nature of Digostics' and AgaMatrix' services bridges a technical gap between GDM testing and post-diagnosis care," said Arif Govani, Chief Digital and Data Officer, Digostics. "However, we are not stopping there in our efforts to make things easier for diabetes midwifery professionals. We are already exploring ways in which we can make the testing and diabetes patient onboarding process even more seamless through full-service integration."
NHS Supply Chain's Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services framework started on the 12th March 2024 and runs for four years. GTT@home's inclusion on this framework makes it easier for NHS hospitals looking to reduce their testing backlogs by drawing on the Digostics service. GTT@home is also regulatory approved for use within the European Union. Additionally, Digostics is currently launching international operations in the Middle East and Asia Pacific to meet the significant demand for oral glucose tolerance home testing in these regions.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.***
About Digostics
Far too many people across the world are living with undiagnosed diabetes.
UK-based Digostics' mission is to enable healthcare providers to identify everyone with diabetes, and those at risk of developing diabetes, by eliminating the common barriers that inhibit accurate and timely testing using the gold standard oral glucose tolerance test (OGTT).
Digostics is proud to offer GTT@home - the world's first home OGTT offering and the most accessible and scalable way for clinical teams to realise their diabetes testing objectives.
To learn more, visit www.digostics.com
About AgaMatrix Europe Ltd
AgaMatrix Europe Ltd is a wholly owned subsidiary of AgaMatrix Inc. based in New Hampshire, USA. AgaMatrix Inc. was acquired by global in-vitro diagnostics company, i-SENS, in July 2023.
AgaMatrix designs, develops, manufactures, and supplies innovative diagnostic and data management technologies for diabetes care.
AgaMatrix Europe is a leading supplier of blood glucose monitoring and support services to Gestational Diabetes Clinics nationwide. The WaveSense JAZZ™ blood glucose test strip is the second most prescribed in the UK. It is used in the WaveSense JAZZ™ WIRELESS meter, which syncs automatically to the AgaMatrix Diabetes Manager app, and is a popular choice for HCPs to monitor Gestational Diabetes.
AgaMatrix has sold over 8 million blood glucose monitors and over 3 billion test strips since the Company's 2001 inception.
Media Contact(s)
Graeme Collins, Digostics
Mobile: +44 (0)7854 664168
Email: gc@digostics.com
SOURCE: Digostics Limited
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Karbon-X Expands European Compliance Market Capabilities With Spanish EU ETS Registry Account9.7.2026 16:00:00 CEST | Press release
Milestone Strengthens Karbon-X's European Regulatory Infrastructure and Expands Its Operational Capabilities Within the World's Largest Compliance Carbon Market CALGARY, AB / ACCESS Newswire / July 9, 2026 / Karbon-X Corp. (OTCQB:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company operating across global carbon markets and climate infrastructure, today announced the establishment of its European Union Emissions Trading System (EU ETS) Registry Account in Spain following regulatory approval from Spain's Office for Climate Change (Oficina Española de Cambio Climático). The milestone further strengthens the Company's regulatory infrastructure in Europe and marks another step in the continued execution of its European growth strategy. Following regulatory approval, the Company's EU ETS Registry Account has been established within the Spanish section of the Union Registry. Final technical activation by the Spanish Registry (RENADE) is expected shortly, aft
Parents Are Underestimating Their Kids' Digital Lives - Especially With AI: New Family Online Safety Institute Research9.7.2026 16:00:00 CEST | Press release
Survey of 4,000+ U.S. and Australian families finds children report doing more online - from social media to generative AI - than their parents realize. WASHINGTON, D.C. / ACCESS Newswire / July 9, 2026 / The Family Online Safety Institute (FOSI) today released Beyond Borders: U.S. and Australian Families on Online Safety, Screen Use, and the Digital Lives of Kids, the fourth wave of its bi-annual Online Safety Survey. When asked whether their child had used generative AI in the past week, 27% of parents said yes. When children were asked the same question about themselves, 38% said yes, an 11-point gap. The pattern held across nearly every online activity measured, including scrolling social media (46% of parents vs. 54% of children) and posting on social media (30% vs. 38%). Fielded in spring 2026 by Ipsos with more than 4,000 parents and children ages 10-17 across the United States and Australia, the research reveals a consistent and significant gap: children report doing more onlin
Haier Europe Appoints Stagwell (STGW) as Creative Agency for the Haier Brand, Following Ingenuity+ Pitch Process9.7.2026 09:35:00 CEST | Press release
LONDON, GB / ACCESS Newswire / July 9, 2026 / Today, Haier Europe appoints Stagwell (NASDAQ:STGW), the challenger network transforming marketing through AI, as its lead creative agency for the Haier Brand, following a competitive pitch process managed by Ingenuity+. Haier strives to deliver premium appliances powered by intelligent technology, naturally designed around customers, empowering them every day as their needs evolve. Stagwell was selected to support the Haier brand through its next phase of growth, bringing its "More Creation, More Possibilities" brand payoff to life through creative communications across Europe. Coordinated by a Client Service Team based in the Italian office, Stagwell will lead creative strategy and campaign development, helping the Haier brand in Europe to translate its vision into a consumer-relevant communication platform across markets and product lines. Stagwell's digital agency, Assembly Digital Commerce, will support with content for online and e-co
Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative8.7.2026 15:00:00 CEST | Press release
Company to conduct feasibility assessment for integrated land restoration and renewable energy initiative as part of its strategy to expand its international climate project development pipeline. CALGARY, AB / ACCESS Newswire / July 8, 2026 / Karbon-X Corp. (OTCQB:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company delivering end-to-end services across global carbon markets and climate infrastructure, today announced a strategic partnership with REGID International ("REGID") to jointly evaluate the Kenya BioHub Initiative, an integrated climate infrastructure program designed to restore degraded land, produce sustainable biomass, and support industrial decarbonization in Kenya. The partnership reflects Karbon-X's disciplined approach to identifying, evaluating, and selectively advancing climate infrastructure opportunities with long-term development potential as part of its strategy to expand its international project development pipeline. The Kenya B
Frame Security Launches KnowBetter as AI Reshapes Social Engineering8.7.2026 14:00:00 CEST | Press release
AI Is Rewriting the Social Engineering Playbook. Security Awareness Training Hasn't Caught Up. Organizations must KnowBetter. NEW YORK CITY, NY / ACCESS Newswire / July 8, 2026 / Security teams have spent two decades training employees to spot a familiar set of red flags: a suspicious link, a misspelled domain, an urgent request for a wire transfer. That approach is now colliding with an attacker toolkit that has changed faster than most awareness programs have. Generative AI has made it possible to clone a voice from a few seconds of audio, generate a passable deepfake video in minutes, and write a phishing email tailored to a specific employee's role, manager, and recent LinkedIn activity. Vishing calls, smishing texts, and video-based impersonation are now standard components of enterprise social engineering campaigns, not edge cases. "Most organizations are still training people to recognize threats from five years ago," said Tal Shlomo, co-founder and CEO of Frame Security, a huma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom